VT News
Jamie Cullum

Jamie Cullum

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • SEC injury reports reveal key absences for top teams ahead of crucial matchups.
  • Pentagon approves Tomahawk missiles for Ukraine, but Trump delays delivery amid concerns over U.S. defense capabilities and Russia's warnings.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • SEC injury reports reveal key absences for top teams ahead of crucial matchups.
  • Pentagon approves Tomahawk missiles for Ukraine, but Trump delays delivery amid concerns over U.S. defense capabilities and Russia's warnings.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jamie Cullum

Top Topics

Trending in U.S.

World

Sport